Roxanne van der Sluijs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roxanne van der Sluijs has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Adrian Baez Ortega
Wellcome Sanger Institute, Hinxton, UK
1 shared publicationAlexander E. E. Verkennis
Hubrecht Institute – KNAW and University Medical Center Utrecht, Utrecht, The Netherlands
1 shared publicationDylan Mckeon
Masonic Cancer Center, University of Minnesota, Minneapolis, USA
1 shared publication- Federico Abascal
Wellcome Sanger Institute, Hinxton, UK
1 shared publication Foster C. Jacobs
Masonic Cancer Center, University of Minnesota, Minneapolis, USA
1 shared publication- Iñigo Martincorena
Wellcome Sanger Institute, Hinxton, UK
1 shared publication
Latest Publications
- Open Access
- 12 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Tissue-specific mutagenesis from endogenous guanine damage is suppressed by Polκ and DNA repair
Knowledge of mutational patterns has expanded significantly, but linking these patterns to specific molecular mechanisms or sources of endogenous DNA damage remains challenging. Translesion synthesis (TLS) is a key determinant of mutagenesis, yet the endogenous lesions that require TLS and how TLS polymerases shape mammalian mutational landscapes are unclear. Here, we characterize somatic mutational patterns across mouse tissues deficient in the TLS polymerase Polκ and find that Polκ suppresses a distinct tissue-specific mutational signature in the liver and kidney. This signature, enriched for C > A/G/T mutations with strong transcriptional-strand bias, indicates that Polκ performs error-free bypass of endogenous guanine adducts. Nucleotide excision repair (NER) acts in parallel, mitigating some of this damage. Targeted adductomics and biochemical analyses identify endogenous N2-dG lesions requiring Polκ-mediated bypass, while untargeted adductomics reveal new guanine lesions that engage NER. These findings uncover the nature of endogenous DNA damage and the coordinated roles of repair and tolerance pathways that limit mutagenesis in tissues.
- 12 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessTissue-specific mutagenesis from endogenous guanine damage is suppressed by Polκ and DNA repair
Knowledge of mutational patterns has expanded significantly, but linking these patterns to specific molecular mechanisms or sources of endogenous DNA damage remains challenging. Translesion synthesis (TLS) is a key determinant of mutagenesis, yet the endogenous lesions that require TLS and how TLS polymerases shape mammalian mutational landscapes are unclear. Here, we characterize somatic mutational patterns across mouse tissues deficient in the TLS polymerase Polκ and find that Polκ suppresses a distinct tissue-specific mutational signature in the liver and kidney. This signature, enriched for C > A/G/T mutations with strong transcriptional-strand bias, indicates that Polκ performs error-free bypass of endogenous guanine adducts. Nucleotide excision repair (NER) acts in parallel, mitigating some of this damage. Targeted adductomics and biochemical analyses identify endogenous N2-dG lesions requiring Polκ-mediated bypass, while untargeted adductomics reveal new guanine lesions that engage NER. These findings uncover the nature of endogenous DNA damage and the coordinated roles of repair and tolerance pathways that limit mutagenesis in tissues.